Other exclusions include an eGFR of more than 25, a history of unstable or rapidly progressing kidney disease, severe gastroparesis or other gastric emptying conditions, pancreatitis, diabetic macular edema, and certain types of diabetic retinopathy
Hsia DS, Grove O, Cefalu WT
Filed lawsuits allege that the manufacturers knew or should have known about their medications links to serious gastrointestinal disorders and have been accused of downplaying adverse events and failing to adequately warn doctors and patients of the dangers of their medications
Endocrinology , 161
These findings suggest that semaglutide can lower the cardiovascular risks significantly in women with obesity going through menopause, regardless of their menopausal stage
During the 2023-2024 fiscal year, Kentucky Medicaid paid out $251 million for GLP-1 medication to treat 76,195 people, according to Cabinet for Health and Family Services spokeswoman Kendra Steele